Cargando…

The emergence of a novel sequence type of MDR Acinetobacter baumannii from the intensive care unit of an Egyptian tertiary care hospital

BACKGROUND AND AIM OF WORK: Acinetobacter baumannii is known for nosocomial outbreaks worldwide. In this study, we aimed to investigate the antibiotic susceptibility patterns and the clonal relationship of A. baumannii isolates from the intensive care unit (ICU) of an Egyptian hospital. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghaith, Doaa Mohammad, Zafer, Mai Mahmoud, Al-Agamy, Mohamed Hamed, Alyamani, Essam J., Booq, Rayan Y., Almoazzamy, Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424338/ https://www.ncbi.nlm.nih.gov/pubmed/28486994 http://dx.doi.org/10.1186/s12941-017-0208-y

Ejemplares similares

Molecular characterization of extended-spectrum beta-lactamases (ESBLs) produced by clinical isolates of Acinetobacter baumannii in Saudi Arabia
por: Alyamani, Essam J., et al.
Publicado: (2015)

Genetic Configuration of Genomic Resistance Islands in Acinetobacter baumannii Clinical Isolates From Egypt
por: Hamed, Samira M., et al.
Publicado: (2022)

Retained colistin susceptibility in clinical Acinetobacter baumannii isolates with multiple mutations in pmrCAB and lpxACD operons
por: Zafer, Mai M., et al.
Publicado: (2023)

Rapid identification of nosocomial Acinetobacter baumannii isolated from a surgical intensive care unit in Egypt
por: Ghaith, Doaa Mohammad, et al.
Publicado: (2015)

Genomic Characterization of Extensively Drug-Resistant NDM-Producing Acinetobacter baumannii Clinical Isolates With the Emergence of Novel bla(ADC-257)
por: Zafer, Mai M., et al.
Publicado: (2021)

Colonization of long term care facility patients with MDR-Gram-negatives during an Acinetobacter baumannii outbreak
por: Zollner-Schwetz, Ines, et al.
Publicado: (2017)

Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii
por: Kumar, Sunil, et al.
Publicado: (2021)

Dissemination of VIM-2 producing Pseudomonas aeruginosa ST233 at tertiary care hospitals in Egypt
por: Zafer, Mai Mahmoud, et al.
Publicado: (2015)

Assessment of the Antibacterial Efficacy of Halicin against Pathogenic Bacteria
por: Booq, Rayan Y., et al.
Publicado: (2021)

Risk Factors and Drug Resistance of the MDR Acinetobacter Baumannii in Pneumonia Patients in ICU
por: Ren, Jichen, et al.
Publicado: (2019)

Computationally Designed AMPs with Antibacterial and Antibiofilm Activity against MDR Acinetobacter baumannii
por: Alsaab, Fahad M., et al.
Publicado: (2023)

Colistin Resistance in Acinetobacter baumannii MDR-ZJ06 Revealed by a Multiomics Approach
por: Hua, Xiaoting, et al.
Publicado: (2017)

Theoretical and Experimental Studies of Phosphonium Ionic Liquids as Potential Antibacterials of MDR Acinetobacter baumannii
por: Metelytsia, Larysa O., et al.
Publicado: (2022)

Differential Gene Expression of Efflux Pumps and Porins in Clinical Isolates of MDR Acinetobacter baumannii
por: AlQumaizi, Khalid I., et al.
Publicado: (2022)

Evaluation of acinetobacter baumannii pneumonia among critically ill patients in a tertiary care hospital in Saudi Arabia
por: Alsulaiman, Duaa, et al.
Publicado: (2020)

715. Bulgecin A lowers Imipenem MICs in Clinical MDR Acinetobacter baumannii (ACB) Strains
por: Skalweit, Marion J, et al.
Publicado: (2019)

Drugs with new lease of life as quorum sensing inhibitors: for combating MDR Acinetobacter baumannii infections
por: Seleem, Noura M., et al.
Publicado: (2020)

First reported nosocomial outbreak of Serratia marcescens harboring bla(IMP-4) and bla(VIM-2) in a neonatal intensive care unit in Cairo, Egypt
por: Ghaith, Doaa Mohammad, et al.
Publicado: (2018)

The occurrence of ESBL-producing Escherichia coli carrying aminoglycoside resistance genes in urinary tract infections in Saudi Arabia
por: Alyamani, Essam J., et al.
Publicado: (2017)

Resistance patterns of multidrug resistant Acinetobacter baumannii in an ICU of a tertiary care hospital, Malaysia
por: Janahiraman, Sivakami, et al.
Publicado: (2015)

Genomic and Phenotypic Analyses of Acinetobacter baumannii Isolates From Three Tertiary Care Hospitals in Thailand
por: Loraine, Jessica, et al.
Publicado: (2020)

Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients
por: Hassan, Reem M., et al.
Publicado: (2021)

Management of Acinetobacter baumannii infection in intensive care units
por: Raine, R, et al.
Publicado: (2021)

The effect of chlorhexidine on Acinetobacter baumannii in intensive care units
por: Martinez-Resendez, Michel F., et al.
Publicado: (2022)

Community acquired multi drug resistant (MDR) Acinetobacter baumannii pneumonia in Malaysia – A case report
por: Mohd, Rozita, et al.
Publicado: (2018)

Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii
por: Singh, Ravinder, et al.
Publicado: (2017)

Antimicrobial Susceptibility and Clonal Relation Between Acinetobacter baumannii Strains at a Tertiary Care Center in Turkey
por: Ece, Gulfem, et al.
Publicado: (2015)

Endemic and epidemic Acinetobacter baumannii clones: a twelve-year study in a tertiary care hospital
por: Villalón, Pilar, et al.
Publicado: (2015)

Burden of Multidrug-Resistant Acinetobacter baumannii Infection in Hospitalized Patients in a Tertiary Care Hospital of Nepal
por: Yadav, Santosh Kumar, et al.
Publicado: (2020)

Carbapenem-resistant Acinetobacter baumannii at a tertiary-care hospital in Botswana: Focus on perinatal environmental exposures
Publicado: (2022)

Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in Vivo
por: Cha, Kyoungeun, et al.
Publicado: (2018)

Pharmacokinetic-pharmacodynamic modelling to investigate in vitro synergy between colistin and fusidic acid against MDR Acinetobacter baumannii
por: Phee, Lynette M, et al.
Publicado: (2019)

CLSI based antibiogram profile and the detection of MDR and XDR strains of Acinetobacter baumannii isolated from urine samples
por: Girija AS, Smiline, et al.
Publicado: (2019)

Using WGS to identify antibiotic resistance genes and predict antimicrobial resistance phenotypes in MDR Acinetobacter baumannii in Tanzania
por: Kumburu, Happiness H, et al.
Publicado: (2019)

In vivo bactericidal effect of colistin–linezolid combination in a murine model of MDR and XDR Acinetobacter baumannii pneumonia
por: Ma, Xiao-Lin, et al.
Publicado: (2020)

MDR Acinetobacter baumanni in the short term and long term acute care setting
por: Whitaker, JL
Publicado: (2011)

Multiple sequence types responsible for healthcare-associated Acinetobacter baumannii dissemination in a single centre in Egypt
por: Al-Hassan, Leena, et al.
Publicado: (2019)

Multidrug-resistant Acinetobacter baumannii infection in the intensive care unit
por: Wiwanitkit, Viroj
Publicado: (2014)

Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from Tertiary Care Hospital in Islamabad, Pakistan
por: Begum, Shahzeera, et al.
Publicado: (2013)

Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India
por: Vijayakumar, Saranya, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d8k8iegnhm698csvbvlf5l6vbt